GSK's CEO, Andrew Witty, was interviewed on
The program follows up our pledge to expand access to medicines in the developing world made during a speech Andrew gave at Harvard in February. The interview explored the different aspects of our commitment--access to medicines, sharing intellectual property and patent pooling.

Leave a comment